Hong Zong

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Shuiling Jin, Ruihua Zhao, Chuang Zhou, Qian Zhong, Jianxiang Shi, Chang Su, Qinglong Li, Xiaoxing Su, Huabin Chi, Xu Lu, Guozhong Jiang, Renyin Chen, Jinming Han, Miao Jiang, Shishi Qiao, Jingjing Liu, Min Song, Lijie Song, Yabing Du, Zhiwei Chang, Meng Wang, Meilian Dong, Yali Zhong, Pu Yu, Xiaojian Zhang, Hong Zong
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial. International journal of cancer (2022)
Miao Jiang, Shuiling Jin, Jinming Han, Tong Li, Jianxiang Shi, Qian Zhong, Wen Li, Wenxue Tang, Qinqin Huang, Hong Zong
Detection and clinical significance of circulating tumor cells in colorectal cancer. Biomarker research 9 (1) (2021)
Shuiling Jin, Zhenzhen Yang, Xin Hao, Wenxue Tang, Wang Ma, Hong Zong
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment. Biomarker research 8 (2020)

Hong Zong.css-eqlu8i{font-size:small;padding-left:4px;}